Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Endothelin converting enzyme inhibitor revealed by Schering-Plough

Aug. 30, 1996

BTG and the New England Medical Center sign marketing agreement

Aug. 23, 1996

Santen reveals neutral endopeptidase inhibitors

Aug. 23, 1996

BMS-186716: Bristol-Myers Squibb's ACE/neutral endopeptidase inhibitor

Aug. 23, 1996

Carvedilol approved for CHF indication in Spanish market

Aug. 23, 1996

Adenosine reuptake inhibitors from Kyowa Hakko

Aug. 23, 1996

Thiazolidinone compounds as antianginal agents from Sankyo

Aug. 23, 1996

Roche reveals EGF-R tyrosine kinase inhibitors

Aug. 23, 1996

Phospholipase A2 inhibitors from SmithKline Beecham

Aug. 23, 1996

European patent protection issued for Hyal's hyaluronan technology

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...